Cyclo Therapeutics, Inc. (CYTH) Prices 2.5M Unit Offering at $5/Unit

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. WDAY
2. JNJ
3. AAPL
4. META
5. AMAT
6. NRIX
7. SPY
8. SUNS
9. SNDX
10. CRDO

Go back to Cyclo Therapeutics, Inc. (CYTH) Prices 2.5M Unit Offering at $5/Unit

Cyclo Therapeutics Announces Pricing of $12.5 Million Public Offering

December 9, 2020 12:52 PM EST

Transaction Includes Uplisting to Nasdaq and Reverse Stock Split

GAINESVILLE, Fla.--(BUSINESS WIRE)-- Cyclo Therapeutics, Inc. (Cyclo Therapeutics or the Company) (NasdaqCM: CYTH) (NasdaqCM: CYTHW), a clinical stage biotechnology company developing a cyclodextrin platform for the treatment of Neurodegenerative Diseases, including their lead candidate (Trappsol® Cyclo) in the treatment of Niemann-Pick Disease Type C (NPC), today announced the pricing of its underwritten public offering of 2,500,000 units at a price to the public of $5.00 per unit. Each unit issued in the offering consists of... More